For Surgeons
CartiONE_Knee_Zoom

Benefits

  • SINGLE SURGERY open/close

      • Cell Mix is prepared in one hour thanks to our patented Rapid Chondrocyte Isolation
      • No second implantation surgery required (in contrast to traditional ACI)
      • No cell culturing
  • YOUR OWN NON-CULTURED CHONDROCYTES open/close

      • Non-cultured chondrocytes are not exposed to laboratory culturing conditions which reduce the potential of chondrocytes to produce hyaline cartilage.
      • Your own cells: no risk of disease transfer or rejection
  • CARTIONE CELL MIX FOR A MORE EFFECTIVE CARTILAGE PRODUCTION. open/close

      • Chondrocytes are mixed with cells from the bone marrow
      • The cell combination boosts cartilage production 
      • No external growth factors required

The CartiONE Cell Service is completed entirely within the operating theatre during a single surgical procedure

How it works

Cartilage biopsy is taken from debridement and non-load bearing area<br>Bone-marrow biopsy is taken
STEP 1

Cartilage biopsy is taken from debridement and non-load bearing area
Bone-marrow biopsy is taken

Bone-marrow biopsy is taken. CartiONE technician isolates and mixes the cells
STEP 2

Bone-marrow biopsy is taken. CartiONE technician isolates and mixes the cells

CartiONE technician isolates and mixes the cells. <br>Cell mix is supplied to surgeon for application on carrier of choice
STEP 3

CartiONE technician isolates and mixes the cells.
Cell mix is supplied to surgeon for application on carrier of choice

Cell mix is supplied to surgeon for application on carrier of choice
STEP 4

Cell mix is supplied to surgeon for application on carrier of choice

Carrier and CartiONE cells are implanted in the defect
STEP 5

Carrier and CartiONE cells are implanted in the defect

CartiONE has been developed in conjunction with the world’s leading joint preservation surgeons.

Clinical outcomes of the first 40 patients treated with CartiONE within the INSTRUCT trial were published in The American Journal of Sports Medicine in May 2020.

CartiONE is ideal for 18–50-year-old skeletally mature patients with focal chondral lesions of the knee of ICRS grades 2 or 3.

It is very important to follow a well-designed rehabilitation program with a professional physiotherapist in order to guarantee proper rehabilitation of the operated knee.

Orteq Sports Medicine
Orteq Sports Medicine

CartiONE is available at dedicated clinics in the United Kingdom and EU.

Joint Preservation
Solutions for
Orthopaedics

At Orteq, we create unique joint preservation solutions for orthopaedic/sports medicine surgeons that encourage a patient’s own natural healing process. Our products offer an innovative regenerative medicine approach to soft tissue defects in joints for patients suffering from injury or degeneration.